Skip to content

Clinical trials

Phase 3 Pancreatic Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 3 Status: Unknown status Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20051
20062
20071
20122
20142
20155
20161
20181
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University4
Astex Pharmaceuticals, Inc.3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
GERCOR - Multidisciplinary Oncology Cooperative Group2
AHS Cancer Control Alberta1
Azienda Ospedaliero, Universitaria Pisana1
Institut Paoli-Calmettes1
Istituti Tumori Giovanni Paolo II1
Klinikum der Universitaet Muenchen, Grosshadern1
Michalis Karamouzis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms26
Bile Duct Neoplasms1
Hyperthermia1
Neoplasm Metastasis1
Pain1
Thromboembolism1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.